Human Bocavirus(HBoV) has to be considered as life-threatening pathogen inadults with atypical pneumonia. Pulsed high-dose glucocorticoid-treatmentmay be beneficial in patients suffering from severe pulmonary disease caused by HBoV or other viruses
6noBackground: During winter 2009 we treated with prolonged corticosteroid infusion eight consecutiv...
Coronavirus has affected more than 128 million humans worldwide with invasionsin 129 countries acros...
Abstract Background COVID‐19 is a highly contagious respiratory disease caused by the SARS‐CoV‐2 vir...
Summary: Human bocavirus (HBoV) is a newly identified virus tentatively assigned to the family Parvo...
Human bocavirus (HBoV), that was first identified in 2005 and classified in Parvoviridae family, is ...
© 2020 Elsevier B.V. Background: Since its first isolation in 2005, Human Bocavirus (HBoV) has been ...
BackgroundCoronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoid...
Until now, April 22, 2020, Covid-19 has been confirmed in 2471136 patients and 203 countries and ter...
BACKGROUND: Human bocavirus (HBoV) is a newly discovered parvovirus and increasing evidences are ava...
BackgroundCoronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoid...
Human bocavirus (HBoV) is a new parvovirus associated with acute respiratory tract infection (ARTI)....
Background: hBoV, a recently discovered parvovirus, can be present in the respiratory tract of patie...
Low-dose dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19)-relate...
Purpose: Infection with COVID-19 potentially can result in severe outcomes and death from “cytokine ...
Treatment strategies for patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
6noBackground: During winter 2009 we treated with prolonged corticosteroid infusion eight consecutiv...
Coronavirus has affected more than 128 million humans worldwide with invasionsin 129 countries acros...
Abstract Background COVID‐19 is a highly contagious respiratory disease caused by the SARS‐CoV‐2 vir...
Summary: Human bocavirus (HBoV) is a newly identified virus tentatively assigned to the family Parvo...
Human bocavirus (HBoV), that was first identified in 2005 and classified in Parvoviridae family, is ...
© 2020 Elsevier B.V. Background: Since its first isolation in 2005, Human Bocavirus (HBoV) has been ...
BackgroundCoronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoid...
Until now, April 22, 2020, Covid-19 has been confirmed in 2471136 patients and 203 countries and ter...
BACKGROUND: Human bocavirus (HBoV) is a newly discovered parvovirus and increasing evidences are ava...
BackgroundCoronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoid...
Human bocavirus (HBoV) is a new parvovirus associated with acute respiratory tract infection (ARTI)....
Background: hBoV, a recently discovered parvovirus, can be present in the respiratory tract of patie...
Low-dose dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19)-relate...
Purpose: Infection with COVID-19 potentially can result in severe outcomes and death from “cytokine ...
Treatment strategies for patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
6noBackground: During winter 2009 we treated with prolonged corticosteroid infusion eight consecutiv...
Coronavirus has affected more than 128 million humans worldwide with invasionsin 129 countries acros...
Abstract Background COVID‐19 is a highly contagious respiratory disease caused by the SARS‐CoV‐2 vir...